{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:15:08Z","timestamp":1787022908473,"version":"build-2736575974"},"reference-count":34,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Hepatitis C virus (HCV) prevalence doubled among pregnant women from 2009 to 2014, reaching 3.4 per 1000 births nationwide. Infants exposed to HCV may acquire HCV by vertical transmission. National guidelines recommend that infants exposed to HCV be tested; however, it is unclear if these recommendations are being followed. Our objectives were to determine if infants exposed to HCV were tested and to determine hospital- and patient-level factors associated with differences in testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>In this retrospective cohort study of infants exposed to HCV who were enrolled in the Tennessee Medicaid program, we used vital statistics\u2013linked administrative data for infants born between January 1, 2005, and December 31, 2014. Infants were followed until 2 years old. Multilevel logistic regression was used to assess the association of HCV testing and hospital- and patient-level characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Only 23% of 4072 infants exposed to HCV were tested. Infants whose mothers were white versus African American (96.6% vs 3.1%; P &amp;lt;.001), used tobacco (78% vs 70%; P &amp;lt;.001), and had HIV (1.3% vs 0.4%; P = .002) were more likely to be tested. Infants exposed to HCV who had a higher median of well-child visits (7 vs 6; P &amp;lt;.001) were more likely to be tested. After accounting for maternal and infant characteristics and health care use patterns, African American infants were less likely to undergo general testing (adjusted odds ratio 0.32; 95% confidence interval, 0.13\u20130.78).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Testing occurred in &amp;lt;1 in 4 infants exposed to HCV and less frequently among African American infants. Public health systems need to be bolstered to ensure that infants exposed to HCV are tested for seroconversion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1542\/peds.2019-2482","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T08:25:13Z","timestamp":1581668713000},"source":"Crossref","is-referenced-by-count":49,"title":["Hepatitis C Testing Among Perinatally Exposed Infants"],"prefix":"10.1542","volume":"145","author":[{"given":"Susan M.","family":"Lopata","sequence":"first","affiliation":[{"name":"Departments of Pediatrics,"},{"name":"Divisions of Neonatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"McNeer","sequence":"additional","affiliation":[{"name":"Vanderbilt Center for Child Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee;"},{"name":"Biostatistics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Dudley","sequence":"additional","affiliation":[{"name":"Health Policy, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Wester","sequence":"additional","affiliation":[{"name":"Tennessee Department of Health, Nashville, Tennessee; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William O.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics,"},{"name":"Vanderbilt Center for Child Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee;"},{"name":"Health Policy, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Carlucci","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics,"},{"name":"Pediatric Infectious Diseases,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia M.","family":"Espinosa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, University of Louisville, Louisville, Kentucky"},{"name":"Division of Pediatric Infectious Diseases and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Dupont","sequence":"additional","affiliation":[{"name":"Biostatistics, and"},{"name":"Health Policy, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Patrick","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics,"},{"name":"Divisions of Neonatology and"},{"name":"Vanderbilt Center for Child Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee;"},{"name":"Health Policy, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2020,3,1]]},"reference":[{"issue":"3","key":"2021121106054590900_B1","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.30297","article-title":"Estimating prevalence of hepatitis C virus infection in the United States, 2013-2016","volume":"69","author":"Hofmeister","year":"2019","journal-title":"Hepatology"},{"issue":"17","key":"2021121106054590900_B2","first-page":"453","article-title":"Increases in hepatitis C virus infection related to injection drug use among persons aged \u226430 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012","volume":"64","author":"Zibbell","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"2021121106054590900_B3","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/cid\/ciu643","article-title":"Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012","volume":"59","author":"Suryaprasad","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"18","key":"2021121106054590900_B4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.15585\/mmwr.mm6618a3","article-title":"Hepatitis C virus infection among women giving birth - Tennessee and United States, 2009-2014","volume":"66","author":"Patrick","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"2021121106054590900_B5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/cid\/ciu447","article-title":"Vertical transmission of hepatitis C virus: systematic review and meta-analysis","volume":"59","author":"Benova","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021121106054590900_B6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejogrb.2015.09.009","article-title":"Risk factors for vertical transmission of hepatitis C virus: a single center experience with 710 HCV-infected mothers","volume":"194","author":"Garcia-Tejedor","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"2021121106054590900_B7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.7326\/0003-4819-158-2-201301150-00575","article-title":"Reducing risk for mother-to-infant transmission of hepatitis C virus: a systematic review for the U.S. Preventive Services Task Force","volume":"158","author":"Cottrell","year":"2013","journal-title":"Ann Intern Med"},{"key":"2021121106054590900_B8","volume-title":"Remington and Klein\u2019s Infectious Diseases of the Fetus and Newborn Infant","author":"Wilson","year":"2015","edition":"8th ed"},{"issue":"10","key":"2021121106054590900_B9","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States, 1999 through 2002","volume":"144","author":"Armstrong","year":"2006","journal-title":"Ann Intern Med"},{"issue":"11","key":"2021121106054590900_B10","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/cid\/ciz063","article-title":"Cost-effectiveness of universal hepatitis C virus screening of pregnant women in the United States","volume":"69","author":"Chaillon","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2021121106054590900_B11","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/cid\/ciw026","article-title":"Failure to test and identify perinatally infected children born to hepatitis C virus-infected women","volume":"62","author":"Kuncio","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"42","key":"2021121106054590900_B12","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.15585\/mmwr.mm6642a3","article-title":"Increased risk for mother-to-infant transmission of hepatitis C virus among Medicaid recipients - Wisconsin, 2011-2015","volume":"66","author":"Watts","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021121106054590900_B13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpeds.2018.07.006","article-title":"Perinatal transmission of hepatitis C virus: defining the cascade of care","volume":"203","author":"Epstein","year":"2018","journal-title":"J Pediatr"},{"issue":"6","key":"2021121106054590900_B14","doi-asserted-by":"crossref","first-page":"e20173273","DOI":"10.1542\/peds.2017-3273","article-title":"Hepatitis C virus screening among children exposed during pregnancy","volume":"141","author":"Chappell","year":"2018","journal-title":"Pediatrics"},{"issue":"19","key":"2021121106054590900_B15","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1080\/14767058.2018.1458836","article-title":"Infant follow-up postdelivery from a hepatitis C viral load positive mother","volume":"32","author":"Towers","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"2021121106054590900_B16","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1542\/peds.2014-3299","article-title":"Prescription opioid epidemic and infant outcomes","volume":"135","author":"Patrick","year":"2015","journal-title":"Pediatrics"},{"key":"2021121106054590900_B17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpeds.2018.03.048","article-title":"Outpatient pharmacotherapy for neonatal abstinence syndrome","volume":"199","author":"Maalouf","year":"2018","journal-title":"J Pediatr"},{"issue":"6","key":"2021121106054590900_B18","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/MPG.0b013e318258328d","article-title":"NASPGHAN practice guidelines: diagnosis and management of hepatitis C infection in infants, children, and adolescents","volume":"54","author":"Mack","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2021121106054590900_B19","volume-title":"Red Book: 2015 Report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics, Committee on Infectious Diseases","year":"2015","edition":"30th ed"},{"key":"2021121106054590900_B20","unstructured":"Centers for Disease Control and Prevention. Hepatitis C questions and answers for health professionals. 2017. Available at: https:\/\/www.cdc.gov\/hepatitis\/hcv\/hcvfaq.htm. Accessed January 1, 2019"},{"key":"2021121106054590900_B21","unstructured":"US Department of Agriculture Economic Research Service.\u2008Documentation. 2018. Available at: https:\/\/www.ers.usda.gov\/data-products\/rural-urban-continuum-codes\/documentation\/#referencedate. Accessed February 18, 2019"},{"issue":"4","key":"2021121106054590900_B22","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/01.AOG.0000263930.28382.2a","article-title":"ACOG practice bulletin No. 86: viral hepatitis in pregnancy","volume":"110","author":"American College of Obstetricians and Gynecologists","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2021121106054590900_B23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1086\/430601","article-title":"Three broad modalities in the natural history of vertically acquired hepatitis C virus infection","volume":"41","author":"European Paediatric Hepatitis C Virus Network","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2021121106054590900_B24","unstructured":"American Association for the Study of Liver Diseases\n          ; Infectious Diseases Society of America. HCV in children. Available at: https:\/\/www.hcvguidelines.org\/unique-populations\/children. Accessed January 10, 2020"},{"issue":"2","key":"2021121106054590900_B25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jmv.20540","article-title":"Accuracy of HCV-RNA PCR tests for diagnosis or exclusion of vertically acquired HCV infection","volume":"78","author":"Polywka","year":"2006","journal-title":"J Med Virol"},{"key":"2021121106054590900_bib33","unstructured":"American Association for the Study of Liver Diseases\n          ; Infectious Diseases Society of America. Initial treatment of adults with HCV infection. Available at: https:\/\/www.hcvguidelines.org\/treatment-naive. Accessed January 10, 2020"},{"issue":"5","key":"2021121106054590900_B26","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jinf.2015.01.009","article-title":"Reliability of risk-based screening for hepatitis C virus infection among pregnant women in Egypt","volume":"70","author":"El-Kamary","year":"2015","journal-title":"J Infect"},{"issue":"1","key":"2021121106054590900_B27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/08897077.2015.1118720","article-title":"Screening and evaluation of hepatitis C virus infection in pregnant women on opioid maintenance therapy: a retrospective cohort study","volume":"37","author":"Krans","year":"2016","journal-title":"Subst Abus"},{"issue":"4","key":"2021121106054590900_B28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3233\/NPM-15915024","article-title":"Hepatitis C virus universal screening versus risk based selective screening during pregnancy","volume":"8","author":"Waruingi","year":"2015","journal-title":"J Neonatal Perinatal Med"},{"issue":"4","key":"2021121106054590900_B29","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jhep.2015.05.015","article-title":"Is antenatal screening for hepatitis C virus cost-effective? A decade\u2019s experience at a London centre","volume":"63","author":"Selvapatt","year":"2015","journal-title":"J Hepatol"},{"key":"2021121106054590900_bib34","unstructured":"American Association for the Study of Liver Diseases\n          ; Infectious Diseases Society of America. HCV in Pregnancy. Available at: https:\/\/www.hcvguidelines.org\/unique-populations\/pregnancy. Accessed January 10, 2020"},{"issue":"1","key":"2021121106054590900_B30","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.2196\/resprot.3822","article-title":"\u201cTest, listen, cure\u201d (TLC) hepatitis C community awareness campaign","volume":"4","author":"Coughlin","year":"2015","journal-title":"JMIR Res Protoc"},{"issue":"3","key":"2021121106054590900_B31","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.23561","article-title":"Institute of Medicine recommendations for the prevention and control of hepatitis B and C","volume":"51","author":"Mitchell","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"2021121106054590900_B32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/SGA.0000000000000310","article-title":"Increasing hepatitis C virus knowledge through an evidence-based educational intervention","volume":"41","author":"Koman","year":"2018","journal-title":"Gastroenterol Nurs"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2019-2482\/1079660\/peds_20192482.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2019-2482\/1079660\/peds_20192482.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T04:03:10Z","timestamp":1639195390000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/145\/3\/e20192482\/76965\/Hepatitis-C-Testing-Among-Perinatally-Exposed"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,1]]},"published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2019-2482","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,1]]},"article-number":"e20192482"}}